Haploid Genetic Screens Identify an Essential Role for PLP2 in the Downregulation of Novel Plasma Membrane Targets by Viral E3 Ubiquitin Ligases

• Richard T. Timms,

  Affiliation Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• Lidia M. Duncan,

  Affiliation Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• Iva A. Tchasovnikarova,

  Affiliation Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• Robin Antrobus,

  Affiliation Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• Duncan L. Smith,

  Affiliation Paterson Institute for Cancer Research, University of Manchester, Withington, Manchester, United Kingdom

  ⨯
• Gordon Dougan,

  Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom

  ⨯
• Michael P. Weekes,

  Affiliation Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• Paul J. Lehner

  * E-mail: pjl30@cam.ac.uk

  Affiliation Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯